Robert Nshimiyimana

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Inflammatory Response

Induced Pluripotent Stem Cells

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Molecular medicine (Cambridge, Mass.)

Proceedings of the National Academy of Sciences of the United States of America

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Hong Yong Peh, Robert Nshimiyimana, Thayse R Brüggemann, Melody G Duvall, Julie Nijmeh, Charles Nicholas Serhan, Bruce David Levy
15-epi-lipoxin A 5 promotes neutrophil exit from exudates for clearance by splenic macrophages. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (14) (2024)
Charles Nicholas Serhan, Nan Chiang, Robert Nshimiyimana
Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Hong Yong Peh, Robert Nshimiyimana, Thayse R Brüggemann, Melody G Duvall, Julie Nijmeh, Charles Nicholas Serhan, Bruce David Levy
15-epi-lipoxin A 5 promotes neutrophil exit from exudates for clearance by splenic macrophages. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (14) (2024)
Hong Yong Peh, Robert Nshimiyimana, Thayse R Brüggemann, Melody G Duvall, Julie Nijmeh, Charles Nicholas Serhan, Bruce David Levy
15-epi-lipoxin A 5 promotes neutrophil exit from exudates for clearance by splenic macrophages. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (14) (2024)
Robert Nshimiyimana, Mélissa Simard, Tarvi Teder, Ana R Rodriguez, Bernd W Spur, Jesper Z Haeggström, Charles Nicholas Serhan
Biosynthesis of resolvin D1, resolvin D2, and RCTR1 from 7,8(S,S)-epoxytetraene in human neutrophils and macrophages. Proceedings of the National Academy of Sciences of the United States of America 121 (37) (2024)
Robert Nshimiyimana, Stephania Libreros, Mélissa Simard, Nan Chiang, Ana R Rodriguez, Bernd W Spur, Jesper Z Haeggström, Charles Nicholas Serhan
Stereochemistry and functions of the new cysteinyl-resolvin, 4S,5R-RCTR1, in efferocytosis and erythrophagocytosis of human senescent erythrocytes. American journal of hematology (2023)
Hong Yong Peh, Thayse R Brüggemann, Melody G Duvall, Robert Nshimiyimana, Julie Nijmeh, Maria A Cinelli, Elliot Israel, Charles Nicholas Serhan, Bruce David Levy
Resolvin D2 regulates type 2 inflammatory responses and promotes resolution of mouse allergic inflammation. Allergy (2023)
Amalie Føreid Reinertsen, Stephania Libreros, Robert Nshimiyimana, Charles Nicholas Serhan, Trond Vidar Hansen
Metabolization of Resolvin E4 by ω-Oxidation in Human Neutrophils: Synthesis and Biological Evaluation of 20-Hydroxy-Resolvin E4 (20-OH-RvE4). ACS pharmacology & translational science 6 (12) (2023)
Stephania Libreros, Robert Nshimiyimana, Brendon Lee, Charles Nicholas Serhan
Infectious Neutrophil deployment is regulated by Resolvin D4. Blood (2023)
Robert Nshimiyimana, Ting Fung Lam, Shubhangi Aggarwal, Charles Nicholas Serhan, Nicos A Petasis
First stereoselective total synthesis of 4( S ),5( S )-oxido-17( S )-hydroxy-6( E ),8( E ),10( Z ),13( Z ),15( E ),19( Z )-docosahexaenoic acid, the biosynthetic precursor of resolvins D3 and D4. RSC advances 12 (19) (2022)
Robert Nshimiyimana, Stephen J Glynn, Charles Nicholas Serhan, Nicos A Petasis
Stereocontrolled total synthesis of Resolvin D4 and 17( R )-Resolvin D4. Organic & biomolecular chemistry (2022)